Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07146412 · ClinicalTrials.gov registry record · NA
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
A NA study of Cognitive Impairment and Mild Cognitive Impairment (MCI), sponsored by HudsonAlpha Institute for Biotechnology.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT07146412 is a NA study of Cognitive Impairment and Mild Cognitive Impairment (MCI) that is actively recruiting participants, run by HudsonAlpha Institute for Biotechnology. The registered enrollment target is 200 participants, below the 664-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07146412, a NA study of Cognitive Impairment and Mild Cognitive Impairment (MCI), is actively recruiting participants, sponsored by HudsonAlpha Institute for Biotechnology.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Many individuals develop dementia, and dementia has multiple causes, yet we currently have limited treatment options. A critical observation of the effectiveness of the available dementia treatments is that they tend to be more effective when started early. Previous studies have shown that multimodal lifestyle interventions can significantly delay the onset of Alzheimer's dementia in individuals with high risk for Alzheimer's or with Mild Cognitive Impairment (MCI). These interventions may be less effective when initiated after dementia has already been diagnosed or is more advanced. This study has two primary goals. The first goal is to assess attitudes around dementia risk for participants throughout the study as they learn of their personalized risk and possible lifestyle factors that may modify that risk. The second goal is to serve as a logistical pilot for the implementation of data collection and processing and multimodal lifestyle intervention to reduce the risk factors of dementia in individuals without current cognitive impairment but who are at high risk of progression to dementia. Secondary goals of this study include better defining what factors contribute the most risk to dementia and identifying sub-types of dementia defined by different genetic and molecular risk factors.
Conditions Studied
Interventions
- BEHAVIORAL Multimodal Lifestyle Intervention
Study Locations (1)
Alabama
- Smith Family Clinic for Genomic Medicine - Huntsville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-05-02 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07146412
The ClinicalTrials.gov registry entry for NCT07146412 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 664-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (70% lower). The listed sponsor is HudsonAlpha Institute for Biotechnology, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which Multimodal Lifestyle Intervention is the first listed.
NCT07146412 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT07146412 about?
NCT07146412 is a clinical study titled "Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study". Many individuals develop dementia, and dementia has multiple causes, yet we currently have limited treatment options. A critical observation of the effectiveness of the available dementia treatments is that they tend to be more effective when started early. Previous studies have shown that multimoda...
What is the current status of trial NCT07146412?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-05-02. Estimated completion is 2026-04-30.
What conditions does trial NCT07146412 study?
This clinical trial studies the following conditions: Cognitive Impairment, Mild Cognitive Impairment (MCI), Alzheimer Disease (AD), Alzheimer Blood Biomarkers.
What interventions are being tested in trial NCT07146412?
The interventions under investigation include: Multimodal Lifestyle Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07146412?
This trial is sponsored by HudsonAlpha Institute for Biotechnology, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07146412 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Mind Your Heart-II
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
-
Train Your Brain SC: Exercise for People With Mild-moderate Cognitive Impairments
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.